LGALS3 and neoplasm: To evaluate the potential use of LGALS3 as an independent prognostic biomarker, a multivariate Cox regression analysis was performed including all the clinicopathological variables (gender, age, tumor node metastasis (TNM) staging, smoking status, and LGALS3).